Cargando…
Conventional Hypoglycaemic Agents and the Risk of Lung Cancer in Patients with Diabetes: A Meta-Analysis
BACKGROUND: Accumulating evidence suggests that hypoglycaemic agents influence lung cancer risk in patients with diabetes. It remains to be fully elucidated whether conventional hypoglycaemic agents (metformin, sulfonylureas, thiazolidinediones [TZDs] or insulin) affect lung cancer incidence in pati...
Autores principales: | Wu, Ying, Liu, Hong-Bing, Shi, Xue-Fei, Song, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055722/ https://www.ncbi.nlm.nih.gov/pubmed/24924771 http://dx.doi.org/10.1371/journal.pone.0099577 |
Ejemplares similares
-
The Management of Type 2 Diabetic Patients with Hypoglycaemic Agents
por: Tsang, Man-Wo
Publicado: (2012) -
Oral Hypoglycaemic Agents: The First Thirty Years
por: Nabarro, John D. N.
Publicado: (1992) -
Interprofessional primary care electronic intervention to reduce hypoglycaemic agent use in high-risk veterans with diabetes
por: Upadhyay, Vaibhav, et al.
Publicado: (2018) -
Design and Synthesis of Pyrazole-3-one Derivatives as Hypoglycaemic Agents
por: Datar, Prasanna A., et al.
Publicado: (2015) -
New Hypoglycaemic Therapies
por: Gale, Edwin A M
Publicado: (2000)